Plus Therapeutics | CYTX - Operating Profit

Stock Price
5.69
Daily Change
0.26 4.79%
Monthly
-12.70%
Yearly
-66.12%
Q2 Forecast
4.67

Plus Therapeutics reported $-5.74M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Baxter International USD -214.2M 415.4M Dec/2025
Cerus USD -1.45M 488K Dec/2024
Dr.Reddys Laboratories INR 13.94B 2.31B Dec/2025
Haemonetics USD 67.4M 8.9M Dec/2025
Infinity Pharmaceuticals USD -10.12M 1.39M Jun/2023
Northwest Biotherapeutics USD -14.32M 481K Sep/2025
Plus Therapeutics USD -5.74M 1.26M Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Starpharma Holdings AUD -873K 1.43M Dec/2025
Sun Pharmaceuticals INR 33.67B 49.9M Sep/2025
Teva Pharmaceutical Industries USD 487M 581M Dec/2025